Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 8/2017

01-08-2017 | Original Contributions

Thrombin Generation Measurements in Patients Scheduled for Laparoscopic Bariatric Surgery

Authors: Jérémie Thereaux, Fanny Mingant, Charles Roche, Hubert Galinat, Francis Couturaud, Karine Lacut

Published in: Obesity Surgery | Issue 8/2017

Login to get access

Abstract

Purpose

Obese patients are known to be in an in vitro hypercoagulable state relative to normal-weight patients. Our study aimed to identify markers of enhanced coagulability (endogenous thrombin potential (ETP)) in morbidly obese patients using the thrombin generation (TG) test.

Materials and Methods

All patients scheduled for laparoscopic bariatric surgery (LBS) between September 1, 2014 and January 31, 2016 were eligible for our prospective study. We used logistic regression to compute the odds ratio (OR) across ETP quartile distributions to evaluate the risk of enhanced TG.

Results

We studied 102 patients, 77.5% were female, mean age was 41.2 ± 12.1 years, and mean BMI was 45.5 ± 7.0 k/m2. Total cholesterol and fibrinogen levels were found to be independent risk factors for patients in the 4th quartile distribution of the ETP distribution (OR (95% CI)) 2.6 (1.2 to 5.4) (P = 0.01) and 2.2 (1.1 to 4.5 (P = 0.03). Patients in the 4th quartile of the ETP distribution had a lower ETP 1 month after surgery (157 (144–196) vs. 120 (98–140); P < 0.001) in parallel with a trend toward lower total cholesterol levels (5.0 ± 0.9 vs. 4.4 ± 1.0; P = 0.06). Fibrinogen levels were stable (4.5 ± 1.0 vs. 4.4 ± 0.9); P = 0.7).

Conclusions

Our study highlights the role of total cholesterol and blood inflammatory marker levels in enhancing ETP in morbidly obese patients. Further studies are necessary to confirm the decreased ETP following LBS with the expected reduced inflammatory marker and total cholesterol levels.
Literature
1.
Shields M, Carroll MD, Ogden CL. Adult obesity prevalence in Canada and the United States. NCHS data brief. 2011;56:1–8.
2.
3.
Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.CrossRefPubMed
4.
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370(21):2002–13.CrossRefPubMedPubMedCentral
5.
Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.CrossRefPubMed
6.
Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–96.CrossRefPubMed
7.
Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366(9497):1640–9.CrossRefPubMed
8.
Severinsen MT, Kristensen SR, Johnsen SP, et al. Anthropometry, body fat, and venous thromboembolism: a Danish follow-up study. Circulation. 2009;120(19):1850–7.CrossRefPubMed
9.
Campello E, Spiezia L, Zabeo E, et al. Hypercoagulability detected by whole blood thromboelastometry (ROTEM(R)) and impedance aggregometry (MULTIPLATE(R)) in obese patients. Thromb Res. 2015;135(3):548–53.CrossRefPubMed
10.
Campello E, Zabeo E, Radu CM, et al. Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events. Thromb Haemost. 2015;113(1):85–96.CrossRefPubMed
11.
Rosito GA, D’Agostino RB, Massaro J, et al. Association between obesity and a prothrombotic state: the Framingham offspring study. Thromb Haemost. 2004;91(4):683–9.PubMed
12.
Pruller F, Raggam RB, Posch V, et al. Trunk weighted obesity, cholesterol levels and low grade inflammation are main determinants for enhanced thrombin generation. Atherosclerosis. 2012;220(1):215–8.CrossRefPubMed
13.
Beijers HJ, Ferreira I, Spronk HM, et al. Body composition as determinant of thrombin generation in plasma: the Hoorn study. Arterioscler Thromb Vasc Biol. 2010;30(12):2639–47.CrossRefPubMed
14.
Beijers HJ, Ferreira I, Spronk HM, et al. Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability: potential role of central adiposity and low-grade inflammation—the Hoorn study. Thromb Res. 2012;129(5):557–62.CrossRefPubMed
15.
Sonnevi K, Tchaikovski SN, Holmstrom M, et al. Obesity and thrombin-generation profiles in women with venous thromboembolism. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. 2013;24(5):547–53.CrossRef
16.
17.
Chantarangkul V, Clerici M, Bressi C, et al. Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability. Haematologica. 2003;88(5):547–54.PubMed
18.
Hron G, Kollars M, Binder BR, et al. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA : the journal of the American Medical Association. 2006;296(4):397–402.CrossRefPubMed
19.
Overweight, obesity, and health risk. National Task Force on the prevention and treatment of obesity. Arch Intern Med. 2000;160(7):898–904.CrossRef
20.
21.
22.
23.
Thereaux J, Veyrie N, Barsamian C, et al. Similar postoperative safety between primary and revisional gastric bypass for failed gastric banding. JAMA surgery. 2014;149(8):780–6.CrossRefPubMed
24.
Thereaux J, Corigliano N, Poitou C, et al. Comparison of results after one year between sleeve gastrectomy and gastric bypass in patients with BMI >/= 50 kg/m(2). Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2015;11(4):785–90.CrossRef
25.
Tripodi A. Thrombin generation assay and its application in the clinical laboratory. Clinical chemistry. 2016
26.
Besser M, Baglin C, Luddington R, et al. High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study. Journal of thrombosis and haemostasis : JTH. 2008;6(10):1720–5.CrossRefPubMed
27.
Cimenti C, Mangge H, Haidl H, et al. Thrombin generation in severely obese children. Journal of thrombosis and haemostasis : JTH. 2006;4(8):1834–6.CrossRefPubMed
28.
Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol. 2005;162(10):975–82.CrossRefPubMed
29.
Horvei LD, Braekkan SK, Mathiesen EB, et al. Obesity measures and risk of venous thromboembolism and myocardial infarction. Eur J Epidemiol. 2014;29(11):821–30.CrossRefPubMed
30.
Finks JF, English WJ, Carlin AM, et al. Predicting risk for venous thromboembolism with bariatric surgery: results from the Michigan bariatric surgery collaborative. Ann Surg. 2012;255(6):1100–4.CrossRefPubMed
31.
Overby DW, Kohn GP, Cahan MA, et al. Prevalence of thrombophilias in patients presenting for bariatric surgery. Obes Surg. 2009;19(9):1278–85.CrossRefPubMed
32.
Hollander SW, Sifft A, Hess S, et al. Identifying the bariatric patient at risk for pulmonary embolism: prospective clinical trial using duplex sonography and blood screening. Obes Surg. 2015;25(11):2011–7.CrossRefPubMed
33.
Paepegaey AC, Genser L, Bouillot JL, et al. High levels of CRP in morbid obesity: the central role of adipose tissue and lessons for clinical practice before and after bariatric surgery. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2015;11(1):148–54.CrossRef
34.
Taura P, Rivas E, Martinez-Palli G, et al. Clinical markers of the hypercoagulable state by rotational thrombelastometry in obese patients submitted to bariatric surgery. Surg Endosc. 2014;28(2):543–51.CrossRefPubMed
35.
Montilla M, Santi MJ, Carrozas MA, et al. Biomarkers of the prothrombotic state in abdominal obesity. Nutricion hospitalaria. 2014;31(3):1059–66.PubMed
36.
Ageno W, Di Minno MN, Ay C, et al. Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysis. Arterioscler Thromb Vasc Biol. 2014;34(11):2478–85.CrossRefPubMedPubMedCentral
37.
Willenberg T, Clemens R, Haegeli LM, et al. The influence of abdominal pressure on lower extremity venous pressure and hemodynamics: a human in-vivo model simulating the effect of abdominal obesity. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 2011;41(6):849–55.CrossRef
38.
Durila M. Nonactivated thromboelastometry able to detect fibrinolysis in contrast to activated methods (EXTEM, INTEM) in a bleeding patient. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. 2015
Metadata
Title
Thrombin Generation Measurements in Patients Scheduled for Laparoscopic Bariatric Surgery
Authors
Jérémie Thereaux
Fanny Mingant
Charles Roche
Hubert Galinat
Francis Couturaud
Karine Lacut
Publication date
01-08-2017
Publisher
Springer US
Published in
Obesity Surgery / Issue 8/2017
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-017-2545-5

Other articles of this Issue 8/2017

Obesity Surgery 8/2017 Go to the issue

Original Contributions

Effects of a Physical Activity Program on Cardiorespiratory Fitness and Pulmonary Function in Obese Women after Bariatric Surgery: a Pilot Study

Original Contributions

Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients

Letter to the Editor

Outcomes of Bariatric Surgery in Patients with Inflammatory Bowel Disease

Original Contributions

Exploring Partners’ Experiences in Living with Patients Who Undergo Bariatric Surgery

Review Article

What Are the Real Procedural Costs of Bariatric Surgery? A Systematic Literature Review of Published Cost Analyses

Original Contributions

Prognostic Value of Negative Coronary CT Angiography in Severely Obese Patients Prior to Bariatric Surgery: a Follow-Up After 6 Years